Cargando…
Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma
Recently, specific driver mutations were identified in chondroblastoma, giant cell tumour of bone and central cartilaginous tumours (specifically enchondroma and central chondrosarcoma), sharing the ability to induce genome-wide epigenetic alterations. In chondroblastoma and giant cell tumour of bon...
Autores principales: | Venneker, Sanne, Szuhai, Karoly, Hogendoorn, Pancras C. W., Bovée, Judith V. M. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968983/ https://www.ncbi.nlm.nih.gov/pubmed/31728625 http://dx.doi.org/10.1007/s00428-019-02699-2 |
Ejemplares similares
-
Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples
por: de Jong, Danielle, et al.
Publicado: (2011) -
A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes
por: Romeo, Salvatore, et al.
Publicado: (2009) -
Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH
por: Cliteur, Vincent PM, et al.
Publicado: (2012) -
Prevalence of cartilaginous tumours as an incidental finding on MRI of the knee
por: Stomp, Wouter, et al.
Publicado: (2015) -
Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic “Stromal” Cells from Giant Cell Tumors of Bone
por: Venneker, Sanne, et al.
Publicado: (2022)